Dopamine d2 Receptor Antikörper (Cytoplasmic Domain)
Kurzübersicht für Dopamine d2 Receptor Antikörper (Cytoplasmic Domain) (ABIN2767572)
Target
Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Cytoplasmic Domain
-
Verwendungszweck
- Dopamine D2 Receptor / DRD2 Rabbit anti-Human Polyclonal (Cytoplasmic Domain) (Unconjugated) Antibody,
-
Aufreinigung
- Immunoaffinity Chromatography
-
-
-
-
Applikationshinweise
- IHC-P (10 µ,g/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 0.1 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- 2-8°C (short-term), -70°C (long-term)
-
-
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Andere Bezeichnung
- Dopamine D2 Receptor
-
Hintergrund
-
Gene Symbol: DRD2
-
Gen-ID
- 1813
-
UniProt
- P14416
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Target
-